Literature DB >> 19858939

Civil society, political mobilization, and the impact of HIV scale-up on health systems in Brazil.

Richard G Parker1.   

Abstract

This article examines the role of civil society in shaping HIV and AIDS policies and programs in Brazil. It focuses on the historical context of the redemocratization of Brazilian society during the 1980s, when the initial response to the epidemic took shape, and emphasizes the role of social movements linked to the progressive Catholic Church, the sanitary reform movement in public health, and the emerging gay rights movement in the early response to the epidemic in Brazil. It highlights the broad-based civil society coalition that took shape over the course of the 1990s and the political alliances that were built up shortly after the 1996 International AIDS Conference in Vancouver, Canada, to pass legislation guaranteeing the right to access to antiretroviral treatment. It emphasizes the continued importance of civil society organizations-in particular, AIDS-related nongovernmental organizations-and leading AIDS activists in exerting continued pressure to guarantee the sustainability of treatment access and the impact that action focused on HIV and AIDS has had on the Brazilian public health system more broadly, particularly through strengthening health infrastructures and providing a model for health-related social mobilization.

Entities:  

Mesh:

Year:  2009        PMID: 19858939      PMCID: PMC3157647          DOI: 10.1097/QAI.0b013e3181bbcb56

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  5 in total

1.  Access to antiretroviral drugs in Brazil.

Authors:  Jane Galvão
Journal:  Lancet       Date:  2002-12-07       Impact factor: 79.321

2.  HIV/AIDS: Latin America & Caribbean. Brazil: ten years after.

Authors:  Jon Cohen
Journal:  Science       Date:  2006-07-28       Impact factor: 47.728

3.  Fighting HIV--lessons from Brazil.

Authors:  Susan Okie
Journal:  N Engl J Med       Date:  2006-05-11       Impact factor: 91.245

4.  [AIDS epidemic trends after the introduction of antiretroviral therapy in Brazil].

Authors:  Inês Dourado; Maria Amélia de S M Veras; Dráurio Barreira; Ana Maria de Brito
Journal:  Rev Saude Publica       Date:  2006-05-22       Impact factor: 2.106

Review 5.  A critical analysis of the Brazilian response to HIV/AIDS: lessons learned for controlling and mitigating the epidemic in developing countries.

Authors:  Alan Berkman; Jonathan Garcia; Miguel Muñoz-Laboy; Vera Paiva; Richard Parker
Journal:  Am J Public Health       Date:  2005-06-02       Impact factor: 9.308

  5 in total
  7 in total

1.  Human immunodeficiency virus prevalence, incidence, and residual risk of transmission by transfusions at Retrovirus Epidemiology Donor Study-II blood centers in Brazil.

Authors:  Ester C Sabino; Thelma T Gonçalez; Anna Bárbara Carneiro-Proietti; Moussa Sarr; João Eduardo Ferreira; Divaldo A Sampaio; Nanci A Salles; David J Wright; Brian Custer; Michael Busch
Journal:  Transfusion       Date:  2011-10-07       Impact factor: 3.157

2.  How HIV treatment could result in effective prevention.

Authors:  Kartik K Venkatesh; Mark N Lurie; Kenneth H Mayer
Journal:  Future Virol       Date:  2010-07       Impact factor: 1.831

3.  Strange bedfellows: the Catholic Church and Brazilian National AIDS Program in the response to HIV/AIDS in Brazil.

Authors:  Laura R Murray; Jonathan Garcia; Miguel Muñoz-Laboy; Richard G Parker
Journal:  Soc Sci Med       Date:  2011-01-27       Impact factor: 4.634

4.  A cross-national analysis of the effects of methadone maintenance and needle and syringe program implementation on incidence rates of HIV in Europe from 1995 to 2011.

Authors:  Phillip L Marotta; Charlotte A McCullagh
Journal:  Int J Drug Policy       Date:  2016-02-26

5.  Phosphoethanolamine and the danger of unproven drugs.

Authors:  Noam Pondé; Evandro de Azambuja; Felipe Ades
Journal:  Ecancermedicalscience       Date:  2016-10-17

6.  The HIV epidemic and human rights violations in Brazil.

Authors:  Monica Malta; Chris Beyrer
Journal:  J Int AIDS Soc       Date:  2013-11-12       Impact factor: 5.396

7.  Access to medicines and hepatitis C in Africa: can tiered pricing and voluntary licencing assure universal access, health equity and fairness?

Authors:  Yibeltal Assefa; Peter S Hill; Anar Ulikpan; Owain D Williams
Journal:  Global Health       Date:  2017-09-13       Impact factor: 4.185

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.